Marcin Heljak

Dr. Marcin Heljak

Faculty of Materials Sciences and Engineering, Warsaw University of Technology, Woloska 141, 02-507 Warsaw, Poland

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2020 in Polymers
Verified
Journal Article
Open access
PDF file
Dorota Kołbuk-KoniecznyDorota Kołbuk-Konieczny
Dorota Kołbuk-Konieczny
Marcin HeljakMarcin Heljak
Marcin Heljak
ECEmilia Choinska
Emilia Choinska
Olga UrbanekOlga Urbanek
Olga Urbanek
Development of hybrid scaffolds and their formation methods occupies an important place in tissue engineering. In this paper, a novel method of 3D hybrid scaffold formation is presented as well as an explanation of the differences in scaffold properties, which were a consequence of different crosslinking mechanisms. Scaffolds were formed from 3D freeze-dried gelatin and electrospun poly(lactide-co-glicolide) (PLGA) fibers in a ratio of 1:1 w/w. In order to enhance osteoblast proliferation, the fibers were coated with hydroxyapatite nanoparticles (HAp) using sonochemical processing. All scaffolds were crosslinked using an EDC/NHS solution. The scaffolds’ morphology was imaged using scanning electron microscopy (SEM). The chemical composition of the scaffolds was analyzed using several methods. Water absorption and mass loss investigations proved a higher crosslinking degree of the hybrid scaffolds than a pure gelatin scaffold, caused by additional interactions between gelatin, PLGA, and HAp. Additionally, mechanical properties of the 3D hybrid scaffolds were higher than traditional hydrogels. In vitro studies revealed that fibroblasts and osteoblasts proliferated and migrated well on the 3D hybrid scaffolds, and also penetrated their structure during the seven days of the experiment.

24 August 2023 in Marine Drugs
Verified
Journal Article
Open access
PDF file
TDTomas Duminis
Tomas Duminis
Marcin HeljakMarcin Heljak
Marcin Heljak
WŚWojciech Święszkowski
Wojciech Święszkowski
Alexander EreskovskyAlexander Ereskovsky
Alexander Ereskovsky
IDIzabela Dziedzic
Izabela Dziedzic
HEHermann Ehrlich
Hermann Ehrlich
Skeletal constructs of diverse marine sponges remain to be a sustainable source of biocompatible porous biopolymer-based 3D scaffolds for tissue engineering and technology, especially structures isolated from cultivated demosponges, which belong to the Verongiida order, due to the renewability of their chitinous, fibre-containing architecture focused attention. These chitinous scaffolds have already shown excellent and promising results in biomimetics and tissue engineering with respect to their broad diversity of cells. However, the mechanical features of these constructs have been poorly studied before. For the first time, the elastic moduli characterising the chitinous samples have been determined. Moreover, nanoindentation of the selected bromotyrosine-containing as well as pigment-free chitinous scaffolds isolated from selected verongiids was used in the study for comparative purposes. It was shown that the removal of bromotyrosines from chitin scaffolds results in a reduced elastic modulus; however, their hardness was relatively unaffected.

1 December 2018 in Micron
Verified
Journal Article
Closed access
Marcin HeljakMarcin Heljak
Marcin Heljak
MMMaryla Moczulska-Heljak
Maryla Moczulska-Heljak
ECEmilia Choinska
Emilia Choinska
ACAdrian Chlanda
Adrian Chlanda
AKAlicja Kosik-Kozioł
Alicja Kosik-Kozioł
WŚWojciech Święszkowski
Wojciech Święszkowski

10 May 2023 in Acta Biomaterialia
Verified
Journal Article
Closed access
SDSylwia Dabrowska
Sylwia Dabrowska
MEMartyna Ekiert
Martyna Ekiert
JKJoanna Karbowniczek
Joanna Karbowniczek
WWWładysław Węglarz
Władysław Węglarz
Marcin HeljakMarcin Heljak
Marcin Heljak
AMAndrzej Młyniec
Andrzej Młyniec

14 February 2023 in Polymers
Verified
Journal Article
Open access
PDF file
Monika BilMonika Bil
Monika Bil
MJMagdalena Jurczyk-Kowalska
Magdalena Jurczyk-Kowalska
KKKamil Kopeć
Kamil Kopeć
Marcin HeljakMarcin Heljak
Marcin Heljak
The effectiveness of multifunctional composites that combine a shape-memory polyurethane (PU) matrix with hydroxyapatite (HA) as a bioactive agent and antibiotics molecules results from a specific composite structure. In this study, structure-function correlations of PU-based composites consisting of 3, 5, and 10 (wt%) of HA and (5 wt%) of gentamicin sulfate (GeS) as a model drug were investigated. The performed analysis revealed that increasing HA content up to 5 wt% enhanced hydrogen-bonding interaction within the soft segments of the PU. Differential-scanning-calorimetry (DSC) analysis confirmed the semi-crystalline structure of the composites. Hydroxyapatite enhanced thermal stability was confirmed by thermogravimetric analysis (TGA), and the water contact angle evaluated hydrophilicity. The shape-recovery coefficient (Rr) measured in water, decreased from 94% for the PU to 86% for the PU/GeS sample and to 88–91% for the PU/HA/GeS composites. These values were positively correlated with hydrogen-bond interactions evaluated using the Fourier-transform-infrared (FTIR) spectroscopy. Additionally, it was found that the shape-recovery process initiates drug release. After shape recovery, the drug concentration in water was 17 μg/mL for the PU/GeS sample and 33–47 μg/mL for the PU HA GeS composites. Antibacterial properties of developed composites were confirmed by the agar-diffusion test against Escherichia coli and Staphylococcus epidermidis.

19 November 2023 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Open access
Marcin HeljakMarcin Heljak
Marcin Heljak
WSWojciech Swieszkowski
Wojciech Swieszkowski
Intravitreal administrated bevacizumab has emerged as an effective antibody for suppressing VEGF expression in age-related macular degeneration (AMD) therapy. This study discusses certain issues related to the sustained release of bevacizumab from intravitreal poly(lactic-co-glycolic acid) (PLGA) microspheres. A computational model elucidating the ocular kinetics of bevacizumab is demonstrated, wherein the release of the drug from PLGA microspheres is modeled using the Koizumi approach, complemented by an empirical model that links the kinetics of bevacizumab release to a size-dependent hydrolytic degradation of the drug-loaded polymeric microparticles. The results of the simulation were then rigorously validated against experimental data. The as-developed model proved remarkably accurate in predicting the time-concentration profiles obtained following the intravitreal injection of PLGA microspheres of significantly different sizes. Notably, the time-concentration profiles of bevacizumab in distinct ocular tissues were almost unaffected by the size of the intravitreally administered PLGA microparticles. Furthermore, the model successfully predicted the retinal concentration of bevacizumab and its fragments (e.g., ranibizumab) administrated in the form of a solution. As such, this model for drug sustained release and ocular transport holds tremendous potential for facilitating the reliable evaluation of planned anti-VEGF therapies.